🇺🇸 FDA
Pipeline program

patients were assigned to receive TNT or iTNT management

OPLAR

Phase 3 small_molecule active

Quick answer

patients were assigned to receive TNT or iTNT management for Rectal Cancer is a Phase 3 program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Rectal Cancer
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials